These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31751502)

  • 1. Levetiracetam-Through a Psychiatric Prism.
    Naguy A
    Prim Care Companion CNS Disord; 2019 Nov; 21(6):. PubMed ID: 31751502
    [No Abstract]   [Full Text] [Related]  

  • 2. Eslicarbazepine acetate as a replacement for levetiracetam in people with epilepsy developing behavioral adverse events.
    Jalihal V; Shankar R; Henley W; Parrett M; Tittensor P; McLean BN; Ahmed A; Sander JW
    Epilepsy Behav; 2018 Mar; 80():365-369. PubMed ID: 29415871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction Tools for Psychiatric Adverse Effects After Levetiracetam Prescription.
    Josephson CB; Engbers JDT; Jette N; Patten SB; Singh S; Sajobi TT; Marshall D; Agha-Khani Y; Federico P; Mackie A; Macrodimitris S; McLane B; Pillay N; Sharma R; Wiebe S
    JAMA Neurol; 2019 Apr; 76(4):440-446. PubMed ID: 30688969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psychiatric Symptoms of Patients With Epilepsy: Characteristics of Psychiatric Adverse Events by Novel Antiepileptic Medications].
    Kanemoto K; Nishida T; Hasegawa N
    Brain Nerve; 2023 Apr; 75(4):375-389. PubMed ID: 37037510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive, behavioural and sleep-related adverse effects on introduction of levetiracetam versus oxcarbazepine for epilepsy.
    Thelengana A; Shukla G; Srivastava A; Singh MB; Gupta A; Rajan R; Vibha D; Pandit AK; Prasad K
    Epilepsy Res; 2019 Feb; 150():58-65. PubMed ID: 30641352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of perampanel with concomitant levetiracetam for patients with drug-resistant epilepsy.
    Kanemura H; Sano F; Aihara M
    Eur J Paediatr Neurol; 2019 Jan; 23(1):197-203. PubMed ID: 30424990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suicidal ideation in epilepsy and levetiracetam therapy.
    Mula M; Sander JW
    Epilepsy Behav; 2007 Aug; 11(1):130-2. PubMed ID: 17544331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric effects of antiepileptic drugs in adults.
    Dussaule C; Bouilleret V
    Geriatr Psychol Neuropsychiatr Vieil; 2018 Jun; 16(2):181-188. PubMed ID: 29877186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases.
    Dinkelacker V; Dietl T; Widman G; Lengler U; Elger CE
    Epilepsy Behav; 2003 Oct; 4(5):537-47. PubMed ID: 14527496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam-Associated Obsessive-Compulsive Symptoms in a Preschooler.
    Yumnam S; Bhagwat C; Saini L; Sharma A; Shah R
    J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):495-496. PubMed ID: 33901133
    [No Abstract]   [Full Text] [Related]  

  • 11. Levetiracetam Induced Neuropsychiatric Manifestation in a 5-year-old Boy.
    Kathiravan M ; Dhawan SR; Singanamala B; Saini L; Sahu JK
    Indian J Pediatr; 2019 Feb; 86(2):193. PubMed ID: 30209735
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel.
    Hansen CC; Ljung H; Brodtkorb E; Reimers A
    Behav Neurol; 2018; 2018():2064027. PubMed ID: 30581496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible lamotrigine-induced neurobehavioral disturbances in children with epilepsy.
    Cardenas JF; Rho JM; Ng YT
    J Child Neurol; 2010 Feb; 25(2):182-7. PubMed ID: 19494356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridoxine supplementation for levetiracetam-related neuropsychiatric adverse events: A systematic review.
    Romoli M; Perucca E; Sen A
    Epilepsy Behav; 2020 Feb; 103(Pt A):106861. PubMed ID: 31917143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serious and reversible levetiracetam-induced psychiatric symptoms after resection of frontal low-grade glioma: two case histories.
    Habets JGV; Leentjens AFG; Schijns OEMG
    Br J Neurosurg; 2017 Aug; 31(4):471-473. PubMed ID: 27760479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experience with levetiracetam in childhood epilepsy].
    Neuwirth M; Saracz J; Hegyi M; Paraicz E; Kollár K; Móser J; Rosdy B; Herczegfalvi A; Fogarasi A
    Ideggyogy Sz; 2006 May; 59(5-6):179-82. PubMed ID: 16786712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonvulsant drugs, folic acid metabolism, fit frequency and psychiatric illness.
    Reynolds EH
    Psychiatr Neurol Neurochir; 1971; 74(2):167-74. PubMed ID: 4948428
    [No Abstract]   [Full Text] [Related]  

  • 18. Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study.
    Belcastro V; Pisani LR; Bellocchi S; Casiraghi P; Gorgone G; Mula M; Pisani F
    J Neurol; 2017 May; 264(5):921-927. PubMed ID: 28315958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy.
    Obeid M; Pong AW
    Epilepsy Res; 2010 Sep; 91(1):101-5. PubMed ID: 20663645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate-induced suicidality.
    Abraham G
    Can J Psychiatry; 2003 Mar; 48(2):127-8. PubMed ID: 12655915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.